MND1 and gastric cancer: FOXA1 directly binds to the MND1 promoter to suppress its transcription, and this suppression-mediated activation of the PI3K/AKT signaling axis concomitantly inhibited gastric cancer progression and enhanced oxaliplatin chemosensitivity [41].